54gene is a healthcare startup that offers a genetics testing platform.
54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research is caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 28, 2022 | Convertable Note | $50M | 7 | — | — | Detail |
Sep 16, 2021 | Series B | $25M | 8 |
![]() |
— | Detail |
Aug 15, 2021 | Series A | — | 1 | — | — | Detail |
Aug 15, 2021 | Series A | — | — | — | — | Detail |
Jul 23, 2021 | Funding Round | $75K | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 14, 2022
![]() |
Series A | $42M | Biotechnology | — |
Aug 30, 2022
![]() |
Seed | $5M | Blockchain | — |
Aug 1, 2022
![]() |
Post-IPO Equity | $100M | Artificial Intelligence | — |
Apr 25, 2022
![]() |
Seed | $1.30M | Blockchain | — |
Apr 20, 2022
![]() |
Pre-seed | $1.50M | Content | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Series B |
![]() |
— | Series A |
![]() |
— | Funding Round |